期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
DNA交联修复基因DCLRE1B对肝癌细胞侵袭和迁移影响的研究 被引量:1
1
作者 邓肇达 王静 +2 位作者 李林成 邹文博 刘荣 《中国普外基础与临床杂志》 CAS 2022年第5期585-593,共9页
目的探究DNA交联修复(DNA cross-link repair,DCLRE)1B基因对肝癌细胞迁移和侵袭能力的影响。方法采用生物信息分析法对DCLRE1B mRNA在肝癌组织中的表达情况及其对肝癌患者预后的影响进行分析;采用免疫组织化学染色法(immunohistochemis... 目的探究DNA交联修复(DNA cross-link repair,DCLRE)1B基因对肝癌细胞迁移和侵袭能力的影响。方法采用生物信息分析法对DCLRE1B mRNA在肝癌组织中的表达情况及其对肝癌患者预后的影响进行分析;采用免疫组织化学染色法(immunohistochemistry,IHC)检测手术切除的肝癌组织及其对应正常肝组织中DCLRE1B蛋白的表达情况;运用慢病毒介导构建DCLRE1B基因沉默的Huh7和HepG2肝癌细胞系,采用蛋白免疫印迹法(Western blot)检测其转染效果;采用划痕实验和Transwell法检测DCLRE1B沉默后的肝癌细胞Huh7和HepG2的迁移和侵袭能力;使用实时荧光定量-聚合酶链反应(quantitative real time-polymerase chain reaction,qRT-PCR)法检测DCLRE1B沉默后上皮间质转化(epithelial-mesenchymal transition,EMT)相关基因改变情况。结果①生物信息分析结果显示:DCLRE1B mRNA在多种肿瘤(包括肝癌)组织中呈高表达(P<0.05);DCLRE1B mRNA的表达与肿瘤的TNM分期相关(P<0.05);肝癌患者的DCLRE1B mRNA相对表达量与其预后相关,高表达组肝癌患者的总生存情况(P=0.038)和无进展生存情况较低表达组缩短(P=0.005);单因素和多因素Cox比例风险回归分析结果显示,DCLRE1B的表达是影响肝癌预后的因素(P<0.05)。②手术切除的肝癌组织中DCLRE1B蛋白表达的阳性率高于正常肝组织(P<0.05)。③细胞实验结果显示:慢病毒介导构建DCLRE1B沉默的肝癌细胞系Huh7和HepG2后,其DCLRE1B蛋白表达均明显下调(P<0.01);沉默DCLRE1B基因后的肝癌细胞的迁移和侵袭能力均明显减弱(P<0.05);沉默DCLRE1B后,肝癌细胞上皮钙粘蛋白、基质金属蛋白酶9和和β-连环蛋白的mRNA表达上调(P<0.05),神经钙粘蛋白和波形蛋白的mRNA表达均下调(P<0.05),锌指转录因子mRNA表达无明显变化,差异无统计学意义(P>0.05)。结论沉默DCLRE1B基因可以抑制肝癌细胞的迁移和侵袭能力,其机制可能与EMT过程有关。 展开更多
关键词 dna交联修复 肝癌 侵袭 迁移 生物信息
原文传递
Formation and repair of DNA-protein crosslink damage 被引量:6
2
作者 Naeh L.Klages-Mundt Lei Li 《Science China(Life Sciences)》 SCIE CAS CSCD 2017年第10期1065-1076,共12页
DNA is constantly exposed to a wide array of genotoxic agents, generating a variety of forms of DNA damage. DNA-protein crosslinks(DPCs)—the covalent linkage of proteins with a DNA strand—are one of the most deleter... DNA is constantly exposed to a wide array of genotoxic agents, generating a variety of forms of DNA damage. DNA-protein crosslinks(DPCs)—the covalent linkage of proteins with a DNA strand—are one of the most deleterious and understudied forms of DNA damage, posing as steric blockades to transcription and replication. If not properly repaired, these lesions can lead to mutations, genomic instability, and cell death. DPCs can be induced endogenously or through environmental carcinogens and chemotherapeutic agents. Endogenously, DPCs are commonly derived through reactions with aldehydes, as well as through trapping of various enzymatic intermediates onto the DNA. Proteolytic cleavage of the protein moiety of a DPC is a general strategy for removing the lesion. This can be accomplished through a DPC-specific protease and and/or proteasome-mediated degradation.Nucleotide excision repair and homologous recombination are each involved in repairing DPCs, with their respective roles likely dependent on the nature and size of the adduct. The Fanconi anemia pathway may also have a role in processing DPC repair intermediates. In this review, we discuss how these lesions are formed, strategies and mechanisms for their removal, and diseases associated with defective DPC repair. 展开更多
关键词 dna-protein crosslinks nucleotide excision repair SPRTN Fanconi anemia
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部